Candidate biomarkers in heart failure with reduced and preserved ejection fraction.

about

Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers.

P2860

Q55343200-A8969657-781F-4CCA-B3D4-9DE1100C8E70

P2860

Candidate biomarkers in heart failure with reduced and preserved ejection fraction.

Item

http://www.wikidata.org/entity/Q38572500

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Candidate biomarkers in heart failure with reduced and preserved ejection fraction.

@en

type

Item

label

Candidate biomarkers in heart failure with reduced and preserved ejection fraction.

@en

prefLabel

Candidate biomarkers in heart failure with reduced and preserved ejection fraction.

@en

P1476

Candidate biomarkers in heart failure with reduced and preserved ejection fraction.

@en

P2093

Christoph Sinning

http://www.w3.org/2001/XMLSchema#string

Dirk Westermann

http://www.w3.org/2001/XMLSchema#string

Elvin Zengin

http://www.w3.org/2001/XMLSchema#string

Renate B Schnabel

http://www.w3.org/2001/XMLSchema#string

Stefan Blankenberg

http://www.w3.org/2001/XMLSchema#string

Tanja Zeller

http://www.w3.org/2001/XMLSchema#string

P2860

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure

Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.

Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.

Biomarkers of coronary artery disease: the promise of the transcriptome.

P304

258-265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/1354750X.2015.1068856

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281196048

http://www.w3.org/2001/XMLSchema#string

P698

26301884

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Candidate biomarkers in heart failure with reduced and preserved ejection fraction.

about

P2860

P2860

Candidate biomarkers in heart failure with reduced and preserved ejection fraction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921